Search results
Results from the WOW.Com Content Network
Insulin glargine sold under the brand name Lantus among others is a long-acting modified form of medical insulin, used in the management of type 1 and type 2 diabetes. [7] It is injected just under the skin . [ 7 ]
Diabetes medications have four main mechanisms of action: [citation needed] Insulin sensitization: Increased sensitivity of insulin receptors on cells leading to decreased insulin resistance, and higher effects of insulin on blood glucose levels. Stimulation of beta cells: This stimulation increases insulin secretion from beta cells of pancreas.
It is administered once daily and has a duration of action that lasts up to 40 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir). [6] [7] The change involves attachment of a hexadecanedioic acid tail to the B29 lysine's "tail" nitrogen. This allows the molecule to ...
Insulin degludec is an ultra-long acting insulin that, unlike insulin glargine, is active at a physiologic pH.The addition of hexadecanedioic acid via an amide linkage to lysine at the B29 position allows for the formation of multi-hexamers in subcutaneous tissues. [16]
Pharmacokinetics: . Process of the uptake of drugs by the body, the biotransformation they undergo, the distribution of the drugs and their metabolites in the tissues, and the elimination of the drugs and their metabolites from the body over a period of time.
From a page move: This is a redirect from a page that has been moved (renamed).This page was kept as a redirect to avoid breaking links, both internal and external, that may have been made to the old page name.
The Urdu Dictionary Board (Urdu: اردو لغت بورڈ, romanized: Urdu Lughat Board) is an academic and literary institution of Pakistan, administered by National History and Literary Heritage Division of the Ministry of Information & Broadcasting. Its objective is to edit and publish a comprehensive dictionary of the Urdu language.
Compared to NPH insulin, lente insulin has a similar but more protracted loss of action after a dose is administered. [7] In the 1990s, recombinant DNA technology allowed for the mass production of the human insulin protein in yeast or bacteria. This led to formulations of recombinant lente human insulin products by the early 2000s. [8]